When was WITT founded?

WITT was founded in 2021 and raised its 1st funding round 3 years after it was founded.

Where is WITT located?

WITT is headquartered in Menlo Park, United States.

Who is the current CEO of WITT?

Rahul Mahadevan of WITT. They have also founded 1 company.

How many employees does WITT have?

As of May 31, 2026, the latest employee count at WITT is 13.

Is WITT a funded company?

WITT is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Nov 13, 2024.

When was the latest funding round of WITT?

WITT's latest funding was a $***** Seed round on Nov 13, 2024, with participation from 2 investors. Its primary sector is Home Healthcare. In United States, the Home Healthcare sector has seen $761M in funding in 2026 to date.

Where does WITT rank among its competitors?

WITT ranks 16th amongst 102 active competitors, of which 23 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Klinic, which secured $24M in Jan, 2026.

Who are the top competitors of WITT?

WITT's top competitors include Goodpath, Klinic and Populus Health Technologies. Among them, Klinic secured the most recent funding round in January, 2026.

WITT - 2026 Company Profile, Team, Funding & Competitors

WITT is a seed company based in Menlo Park (United States), founded in 2021 by Rahul Mahadevan. It operates as a Social platform that enables patients to easily ask for support for treatment. WITT has raised an undisclosed amount in funding from Sopris Capital. The company has 102 active competitors, including 23 funded and 4 that have exited. Its top competitors include companies like Goodpath, Klinic and Populus Health Technologies.

Company Details

WiTT Forever is a social platform that empowers patients to connect with their support system and receive the help they need during treatment and recovery. The platform facilitates a registry of patient needs and allows friends and family to provide support in various ways, fostering a sense of community and reducing the emotional burden of cancer care. With a focus on non-clinical challenges, WiTT Forever addresses the financial, emotional, and practical struggles patients face, ultimately improving outcomes and quality of life.

Website: www.wittforever.com/
Social
Email ID: *****@wittforever.com
Phone Number: +1 **********

Key Metrics

Founded Year

2021

Location

Menlo Park, United States

Stage

Seed

Latest Funding Round

Seed, Nov 13, 2024, $*****

Investors

Sopris Capital & 1 more

Ranked

16^th among 102 active competitors

Employee Count

13 as on May 31, 2026

Similar Companies

Goodpath & 361 more

View WITT's full profile

WITT has raised funding over 1 round. Its latest funding round was a Seed round on Nov 13, 2024 for $*****. 2 investors participated in its latest round. WITT has 2 institutional investors.

Here is the list of recent funding rounds of WITT:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 13, 2024	1868858	Seed	5399916	3825682	4729680	9908428

Access funding benchmarks and valuations. Sign up today!

View details of WITT's funding rounds and investors

The founders of WITT is Rahul Mahadevan. Rahul Mahadevan is the CEO of WITT.

Here are the details of WITT's key team members:

Rahul Mahadevan: Founder & CEO of WITT.
Contact Info: 1 email address

View details of WITT's Founder profiles and Board Members

WITT's employee count trend

WITT has 13 employees as of May 26. Here is WITT's employee count trend over the years:

Uncover WITT's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of WITT include Goodpath, Klinic and Populus Health Technologies. Here is the list of Top 10 competitors of WITT, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Goodpath 2018, Cambridge (United States), Series A	Provider of healthcare plans for back pain, sleep, and IBS issues	$22M	Global Founders Capital, MassMutual Ventures ... & 9 others	56/100
2nd	Klinic 2021, Seattle (United States), Series B	Provider of addiction treatment services, specializing in well child check-ups and acute pediatric medical care	$24M	Proofpoint Capital, Wicklow Capital & 2 others	47/100
3rd	Populus Health Technologies 2018, Princeton (United States), Series A	Provider of virtual care platform connecting brands and healthcare professionals	$5M	-	46/100
4th	Dexafit 2018, Chamblee (United States), Unfunded	Chains providing body composition analysis, fitness testing, and metabolic assessments	-	-	43/100
5th	ClinNEXUS 2019, Los Angeles (United States), Series A	Provider of patient care services at home	$750K	SUNCOAST VENTURES, Expert DOJO	40/100
6th	Alchemy Health 2023, San Francisco (United States), Seed	Provider of comprehensive platform for in-house pharmacy solutions, offering physical, clinical, and digital infrastructure to support the operation of on-site pharmacies for safety net clinics, focused on advancing HIV access and equity	$31M	Andreessen Horowitz, Banc of California & 5 others	40/100
7th	SmartScripts 2015, Washington (United States), Series A	Personalized pharmacy delivering pre-sorted medication packs for better care and adherence	$19.4M	Iowa Farm Bureau, Next Level Ventures & 1 others	39/100
8th	WovenX Chicago (United States), Seed	Provider of virtual and integrated gastroenterology care solutions	$610K	-	39/100
9th	M Health Fairview 2019, Minneapolis (United States), Funding Raised	Healthcare provider offering accessible care through online platforms	-	HHS	37/100
10th	Isaac Health 2022, New York City (United States), Series A	Virtual clinic specializing in brain health, dementia care, diagnosis, treatment, and caregiver support	$16.3M	Flare Capital Partners, B Capital & 9 others	35/100
16th	WITT 2021, Menlo Park (United States), Seed	Social platform that enables patients to easily ask for support for treatment	-	Sopris Capital, LEAD	28/100